Zahra Kassamali Escobar

Zahra Kassamali Escobar

Auto-generated profile, based on publicly available information

Zahra Kassamali Escobar

University of Washington School of Pharmacy

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2022 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Open access
PDF file
FLFunnce Liu
Funnce Liu
BMBarbara MacDonald
Barbara MacDonald
RJRupali Jain
Rupali Jain
CBChloe Bryson-Cahn
Chloe Bryson-Cahn
NMNatalia Martinez-Paz
Natalia Martinez-Paz
ZEZahra Kassamali Escobar
Zahra Kassamali Escobar
Asymptomatic bacteriuria (ASB) is common among hospitalized patients and often leads to inappropriate antimicrobial use. Data from critical-access hospitals are underrepresented. To target antimicrobial stewardship efforts, we measured the point prevalence of ASB and detected a high frequency of ASB overtreatment across academic, community, and critical-access hospitals.

6 November 2023 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Open access
PDF file
WHWhitney Hartlage
Whitney Hartlage
CBChloe Bryson-Cahn
Chloe Bryson-Cahn
ACAlyssa Y. Castillo
Alyssa Y. Castillo
RJRupali Jain
Rupali Jain
JLJohn B. Lynch
John B. Lynch
ZEZahra Kassamali Escobar
Zahra Kassamali Escobar
We evaluated the prevalence and treatment of asymptomatic bacteriuria (ASB) in 17 critical-access hospitals. Among 891 patients with urine cultures from September 2021 to June 2022, 170 (35%) had ASB. Also, 76% of patients with ASB received antibiotics for a median duration of 7 days, demonstrating opportunities for antimicrobial stewardship.

19 February 2021 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Closed access
PDF file
JHJoanne Huang
Joanne Huang
ZEZahra Kassamali Escobar
Zahra Kassamali Escobar
TBTodd S. Bouchard
Todd S. Bouchard
JLJose Mari G. Lansang
Jose Mari G. Lansang
RJRupali Jain
Rupali Jain
CBChloe Bryson-Cahn
Chloe Bryson-Cahn
The MITIGATE toolkit was developed to assist urgent care and emergency departments in the development of antimicrobial stewardship programs. At the University of Washington, we adopted the MITIGATE toolkit in 10 urgent care centers, 9 primary care clinics, and 1 emergency department. We encountered and overcame challenges: a complex data build, choosing feasible outcomes to measure, issues with accurate coding, and maintaining positive stewardship relationships. Herein, we discuss solutions to challenges we encountered to provide guidance for those considering using this toolkit.

15 June 2022 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Open access
PDF file
BWBrian J. Werth
Brian J. Werth
TDThomas J. Dilworth
Thomas J. Dilworth
ZEZahra Kassamali Escobar
Zahra Kassamali Escobar
AGAlan E. Gross
Alan E. Gross
KSKatie J. Suda
Katie J. Suda
KKKristi Kuper
Kristi Kuper
Objectives:To identify characteristics of US health systems and end users that report antimicrobial use and resistance (AUR) data, to determine how NHSN AUR data are used by hospitals and health systems and end users, and to identify barriers to AUR reporting.Design:An anonymous survey was sent to Society of Infectious Diseases Pharmacists (SIDP) and Society for Healthcare Epidemiology of America (SHEA) Research Network members.Methods:Data were collected via Survey Monkey from January 21 to February 21, 2020. Respondent and hospital data were analyzed using descriptive statistics.Results:We received responses from 238 individuals across 43 US states. Respondents were primarily pharmacists (84%), from urban areas, (44%), from nonprofit medical centers (81%), and from hospitals with >250 beds (72%). Also, 62% reported data to the AU module and 19% reported data to the AR module. Use of software for local AU or AR tracking was associated with increased reporting to the AU module (19% vs 64%) and the AR module (2% vs 30%) (P < .001 each). Only 36% of those reporting data to the AU module used NHSN AUR data analysis tools regularly and only 9% reported data to the AR module regularly. Technical challenges and time and/or salary support were the most common barriers to AUR participation cited by all respondents. Among those not reporting AUR data, increased local expectations to report and better software solutions were the most commonly identified solutions to increase AUR reporting.Conclusions:Efforts to increase AUR reporting should focus on software solutions and salary support for data-entry activities. Increasing expectations to report may incentivize local resource allocation to improve AUR reporting rates.

18 August 2023 in Transplant Infectious Disease
Verified
Journal Article
Closed access
FTFrank Tverdek
Frank Tverdek
ZEZahra Kassamali Escobar
Zahra Kassamali Escobar
CLCatherine Liu
Catherine Liu
RJRupali Jain
Rupali Jain
JLJulian Lindsay
Julian Lindsay

11 November 2024 in Antimicrobial Stewardship & Healthcare Epidemiology
Verified
Journal Article
Open access
PDF file
ZKZahra Kassamali-Escobar
Zahra Kassamali-Escobar
WHWhitney Hartlage
Whitney Hartlage
JCJeannie D. Chan
Jeannie D. Chan
ACAlyssa Castillo
Alyssa Castillo
NMNatalia Martinez-Paz
Natalia Martinez-Paz
CBChloe Bryson-Cahn
Chloe Bryson-Cahn
We describe our experience implementing an intensive quality improvement cohort pilot focused on managing asymptomatic bacteriuria in 19 critical access hospitals. Participation in the pilot was high, and almost all sites identified an improvement goal and collected clinical data. Barriers to implementation included staffing shortages, turnover, and lack of bandwidth.